STANISIC, S.; BERTOLOTTO, A.; BERTO, P.; DI PROCOLO, P.; MORAWSKI, J. The cost-effectiveness of alemtuzumab in the management of relapse-remitting multiple sclerosis in Italy. Global & Regional Health Technology Assessment, [S. l.], v. 6, n. 1, 2019. DOI: 10.33393/grhta.2019.465. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/465. Acesso em: 15 aug. 2022.